Alzheimer disease genetic risk factorAPOEe4 and cognitive abilities in 111,739 UK Biobank participants
Author(s) -
Donald M. Lyall,
Joey Ward,
Stuart J. Ritchie,
Gail Davies,
Breda Cullen,
Carlos LópezdeCelis,
Mark E.S. Bailey,
Jana Anderson,
Jonathan J. Evans,
D McKay,
Andrew M. McIntosh,
Naveed Sattar,
Daniel J. Smıth,
Ian J. Deary,
Jill P. Pell
Publication year - 2016
Publication title -
age and ageing
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.014
H-Index - 143
eISSN - 1468-2834
pISSN - 0002-0729
DOI - 10.1093/ageing/afw068
Subject(s) - dementia , apolipoprotein e , medicine , cognitive decline , biobank , confounding , cognition , disease , mendelian randomization , risk factor , gerontology , alzheimer's disease , effects of sleep deprivation on cognitive performance , psychiatry , bioinformatics , genetics , genotype , biology , genetic variants , gene
he apolipoprotein (APOE) e4 locus is a genetic risk factor for dementia. Carriers of the e4 allele may be more vulnerable to conditions that are independent risk factors for cognitive decline, such as cardiometabolic diseases.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom